Riverview Trust Company’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-70
Closed -$636 801
2024
Q4
$636 Hold
70
﹤0.01% 731
2024
Q3
$643 Buy
+70
New +$579 ﹤0.01% 739
2023
Q2
Sell
-472
Closed -$12.2K 747
2023
Q1
$12.2K Hold
472
0.01% 628
2022
Q4
$11K Buy
+472
New +$12.7K 0.01% 664
2022
Q2
Sell
-226
Closed -$16K 855
2022
Q1
$16K Buy
+226
New +$16.3K 0.01% 589

Other funds holding TDOC

Riverview Trust Company's TDOC Position: Q1 2025 in Review

Riverview Trust Company sold out of Teladoc Health (TDOC) in Q1 2025, closing a stake of 70 shares — an estimated $636 sold.

Riverview Trust Company first reported a position in TDOC in Q1 2022 and held it in 5 quarters. The position peaked at $16K in Q1 2022. 384 funds tracked by Wall St. Rank hold TDOC as of Q1 2025.

  • Riverview Trust Company reported no remaining Teladoc Health position as of Q1 2025 after selling out during the quarter.
  • Riverview Trust Company sold 70 Teladoc Health shares in Q1 2025, an estimated $636.
  • Riverview Trust Company first reported a position in Teladoc Health in Q1 2022 and held it in 5 quarters.
  • Riverview Trust Company's Teladoc Health position peaked at $16K in Q1 2022.
  • 384 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2025.

Based on Riverview Trust Company's 13F filing for Q1 2025, filed 11 Apr 2025.